InvestSMART

Atomo Diagnostics Limited (ASX:AT1)

ALERT: Price-sensitive ASX Announcement for AT1
Current share price for AT1 : $0.017 -0.023 (-57.50%)+
Announcement
Release
6 Feb 2026 8:26AM
Price at Release
$0.040
Full Release
download
Summary
Atomo Diagnostics Limited has secured an order valued at approximately $630,000 to supply HIV Self-Tests for the National Association of People with HIV Australia (NAPWHA) mail-out program. This initiative, funded by the Federal Government, aims to increase testing among high-risk groups and is supported by Grindr. The program has been successful in promoting free and accessible HIV self-testing, helping to raise awareness. Atomo Diagnostics, through its collaborative efforts with NAPWHA and other partners, continues to play a crucial role in this public health initiative.
Key Points
  • Atomo Diagnostics Limited secures Australian order for HIV Self-Tests worth approximately $630,000.
  • The order supports the NAPWHA HIV Self-Test mail-out program, funded by the Federal Government.
  • The program has significantly increased testing rates among high-risk populations.
  • The initiative is supported by the social networking app Grindr.
  • Atomo has a strong partnership with NAPWHA and other partners in Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.